financetom
Business
financetom
/
Business
/
MillerKnoll Q3 Earnings Lower, Revenue Higher; Shares Tumble
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MillerKnoll Q3 Earnings Lower, Revenue Higher; Shares Tumble
Mar 25, 2026 2:01 PM

04:32 PM EDT, 03/25/2026 (MT Newswires) -- MillerKnoll ( MLKN ) reported fiscal Q3 non-GAAP net income late Wednesday of $ 0.43 per diluted share, down from $0.44 a year earlier.

Analysts polled by FactSet expected $0.45.

Revenue for the quarter ended Feb. 28 was $926.6 million, up from $876.2 million a year earlier.

Analysts expected $942 million.

For fiscal Q4, the company expects adjusted EPS of $0.49 to $0.55 on revenue of $955 million to $995 million.

Analysts are looking for $0.61 and $993.2 million, respectively.

Shares were over 14% lower in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Interpace Biosciences Q3 revenue down 
Interpace Biosciences Q3 revenue down 
Nov 12, 2025
Overview * Interpace Q3 revenue falls 29% yr/yr, but rises 22% from pro forma results * Company reports record thyroid test volumes and cash collections in Q3 * Interpace focuses on lab efficiency and AI, supporting strategic investments Outlook * Company did not provide specific future guidance in press release Result Drivers * RECORD THYROID TEST VOLUME - Co achieved...
Cancer diagnostics firm Celcuity posts smaller-than-expected Q3 adjusted loss per share 
Cancer diagnostics firm Celcuity posts smaller-than-expected Q3 adjusted loss per share 
Nov 12, 2025
Overview * Celcuity ( CELC ) Q3 adjusted loss per share and adjusted net loss beat analyst expectations * Company's operating expenses increased to $42.8 mln in Q3 2025 * Celcuity on track to submit NDA for gedatolisib in Q4 2025 Outlook * Celcuity expects topline data from PIK3CA mutant cohort in late Q1 2026 or Q2 2026 * Celcuity...
Merck & Co. Insider Sold Shares Worth $616,395, According to a Recent SEC Filing
Merck & Co. Insider Sold Shares Worth $616,395, According to a Recent SEC Filing
Nov 12, 2025
04:12 PM EST, 11/12/2025 (MT Newswires) -- Cristal N Downing, Chief Communications & Public Affairs Officer, on November 10, 2025, sold 7,085 shares in Merck & Co. ( MRK ) for $616,395. SEC Filing: https://www.sec.gov/Archives/edgar/data/310158/000031015825000061/xslF345X05/form4.xml ...
Edgewell Personal Care Announces Sale of Feminine Care Business to Essity for $340M
Edgewell Personal Care Announces Sale of Feminine Care Business to Essity for $340M
Nov 12, 2025
Transaction streamlines Edgewell's portfolio and allows the personal care brand to focus on areas of competitive leadership SHELTON, Conn., Nov. 12, 2025 /PRNewswire/ -- Edgewell Personal Care Company ( EPC ) today announced that it has entered into a definitive agreement to sell its feminine care business to Essity, a leading global health and hygiene company based in Sweden,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved